These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865 [TBL] [Abstract][Full Text] [Related]
3. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age. Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study. Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP; J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371 [TBL] [Abstract][Full Text] [Related]
6. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. de Vries AB; Janse M; Blokzijl H; Weersma RK World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965 [TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey. Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543 [TBL] [Abstract][Full Text] [Related]
10. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311 [TBL] [Abstract][Full Text] [Related]
11. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470 [TBL] [Abstract][Full Text] [Related]
12. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. Zheng HH; Jiang XL Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805 [TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. Wang R; Leong RW World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis. Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520 [TBL] [Abstract][Full Text] [Related]
19. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Florin TH; Pandeya N; Radford-Smith GL Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]